On Monday, 28th November 2022 the University of Nairobi through the University of Nairobi Institute of Tropical and Infectious Diseases (UNITID) and Roche entered into a collaborative agreement through the signing of an MoU.
While elaborating more on this collaboration, the Director of UNITID, Prof, Julius Oyugi announced that Roche has identified UNITID as a suitable partner to work with on clinical trials on cancer drugs starting January 2023.
During the signing Ceremony, Frank Loeffler, the General Manager, of East Africa of Roche emphasized the importance of investing in research citing that research is generational and it is the backbone of Public Health. “We do not research today for tomorrow but for generations to come. I want to urge the Kenyan government to invest more in research and development. He noted that Roche spends 14Bn USD on Research and Development annually while they spend 6 Bn on manufacturing.”
On his part, the Vice Chancellor of UoN, Prof. Stephen Kiama applauded the move of partnership and focused research on cancer citing that, ‘Cancer has been a menace the world over and we hear a lot of issues such as a diet that have been the cause of cancer. If we can just arrest this cancer through research that can be such a relief.”
Dr Ochieng, The Programme Coordinator of the Oncology Clinical trials noted that this is the first training programme to train oncologists in Kenya. Over the years, Oncologists have been training outside the country. It is our hope that we train oncologists who can make a difference and who can mentor other oncologists.
Dr Kahumburu, a resident Oncologist at the Oncology Clinical trials appreciated the move by the two institutions noting that ‘as students, they have immensely benefited from the programme and had a chance to work with Mayo Clinic, Harvard and Pennsylvania throughout the research.”
Content created and supplied by: Football⚽️🥅🏟 (via Opera News )
Opera News is a free to use platform and the views and opinions expressed herein are solely those of the author and do not represent, reflect or express the views of Opera News. Any/all written content and images displayed are provided by the blogger/author, appear herein as submitted by the blogger/author and are unedited by Opera News. Opera News does not consent to nor does it condone the posting of any content that violates the rights (including the copyrights) of any third party, nor content that may malign, inter alia, any religion, ethnic group, organization, gender, company, or individual. Opera News furthermore does not condone the use of our platform for the purposes encouraging/endorsing hate speech, violation of human rights and/or utterances of a defamatory nature. If the content contained herein violates any of your rights, including those of copyright, and/or violates any the above mentioned factors, you are requested to immediately notify us using via the following email address operanews-external(at)opera.com and/or report the article using the available reporting functionality built into our Platform See More